- Global Pharma News & Resources

Physicians' Education Resource® Will Host the 13th Annual New York Lung Cancer Symposium®

Physicians’ Education Resource® (PER®), the leading resource for oncology and hematology continuing medical education, will present its 13th Annual New York Lung Cancers Symposium® on Saturday, Nov. 10, at the New York Marriott Marquis. The program will be co-chaired by renowned oncologists, Mark G. Kris, M.D., attending physician, thoracic oncology service, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, and Roman Perez-Soler, M.D., chairman, department of oncology, Montefiore Medical Center, professor of medicine and molecular pharmacology, deputy cancer center director, Albert Einstein College of Medicine in New York.

“We look forward to offering attendees an all new redesigned exciting meeting at this year’s 13th Annual New York Lung Cancer Symposium®,” said Phil Talamo, president of PER®. “This year’s program will provide attendees with the chance to preview upcoming advances in local and systemic therapies for thoracic malignances.”

Directed toward medical and radiation oncologists, thoracic surgeons, and pulmonologists, the symposium is a one-day interactive educational program that will provide attendees with a comprehensive overview of lung cancer diagnosis and multidisciplinary treatment. This year’s meeting has been altered to increase attendees’ knowledge and competence of lung cancer therapy, starting with the roles that surgery, radiology, pulmonology and pathology play in ensuring the most accurate diagnoses of lung cancers. Attendees will also get the opportunity to hear experts from the New York area discussing optimal approaches for early-stage and locally advanced disease, as well as hear them present the latest data on immunotherapy and targeted agents in metastatic lung cancers.

For registration and more information, please visit

About Physicians’ Education Resource ® (PER ® )

Since 1995, PER® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas and continues to grow its therapeutic reach outside of oncology. While continuing to expand into topics outside of oncology, PER® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. In 2018, PER® will develop and implement 21 historic annual legacy conferences in the United States and Europe, along with many renowned online learning formats. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at and

View source version on

Editor Details

Last Updated: 30-Oct-2018